Pro-Dex, Inc. (PDEX)
USD 45.73
(-5.61%)
USD 45.73
(-5.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 8.33 Million USD | 25.9% |
| 2023 | 6.61 Million USD | 15.99% |
| 2022 | 5.96 Million USD | 11.67% |
| 2021 | 8.07 Million USD | -38.52% |
| 2020 | 8.75 Million USD | 51.18% |
| 2019 | 5.42 Million USD | 37.14% |
| 2018 | 3.96 Million USD | 22.11% |
| 2017 | 3.4 Million USD | 147.58% |
| 2016 | 1.38 Million USD | 535.53% |
| 2015 | 138 Thousand USD | -15.64% |
| 2014 | -220 Thousand USD | 79.01% |
| 2013 | -1.31 Million USD | -82.45% |
| 2012 | -718 Thousand USD | -118.22% |
| 2011 | 3.94 Million USD | 102.94% |
| 2010 | -2.45 Million USD | 512.62% |
| 2009 | -401 Thousand USD | -67.25% |
| 2008 | 1.03 Million USD | -25.25% |
| 2007 | 1.32 Million USD | -11.9% |
| 2006 | 1.47 Million USD | -41.74% |
| 2005 | 2.64 Million USD | 21.59% |
| 2004 | 2.19 Million USD | 221.71% |
| 2003 | 306 Thousand USD | 156.23% |
| 2002 | -1.27 Million USD | -224.4% |
| 2001 | -261 Thousand USD | -81.26% |
| 2000 | 2.86 Million USD | 442.93% |
| 1999 | -8.82 Million USD | -149.44% |
| 1998 | 2.9 Million USD | 38.23% |
| 1997 | 1.6 Million USD | -44.74% |
| 1996 | 3.8 Million USD | 171.43% |
| 1995 | 1.1 Million USD | 27.27% |
| 1994 | 900 Thousand USD | 266.67% |
| 1993 | 100 Thousand USD | -57.14% |
| 1992 | 600 Thousand USD | 600.0% |
| 1991 | 100 Thousand USD | -80.0% |
| 1990 | 500 Thousand USD | 400.0% |
| 1989 | 100 Thousand USD | 109.09% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 2.49 Million USD | 135.09% |
| 2024 Q2 | 1.08 Million USD | 355.53% |
| 2024 Q1 | 2.13 Million USD | -122.21% |
| 2024 FY | - USD | 20.54% |
| 2024 Q4 | 2.65 Million USD | 6.32% |
| 2023 Q2 | 1.33 Million USD | -1.91% |
| 2023 Q4 | 1.93 Million USD | -15.49% |
| 2023 Q1 | 1.36 Million USD | 10.74% |
| 2023 FY | - USD | 15.99% |
| 2023 Q3 | 2.28 Million USD | 71.24% |
| 2022 Q1 | 1.52 Million USD | 148.94% |
| 2022 Q4 | 1.22 Million USD | 1.15% |
| 2022 Q3 | 1.21 Million USD | -32.84% |
| 2022 Q2 | 1.8 Million USD | 18.55% |
| 2022 FY | - USD | 11.67% |
| 2021 Q1 | 1.74 Million USD | -45.08% |
| 2021 Q2 | 711 Thousand USD | -59.14% |
| 2021 Q4 | 613 Thousand USD | -70.64% |
| 2021 Q3 | 2.08 Million USD | 193.67% |
| 2021 FY | - USD | -38.52% |
| 2020 FY | - USD | 51.18% |
| 2020 Q3 | 1.85 Million USD | 0.65% |
| 2020 Q2 | 1.84 Million USD | 10.88% |
| 2020 Q1 | 1.66 Million USD | 34.96% |
| 2020 Q4 | 3.16 Million USD | 70.6% |
| 2019 Q3 | 1.1 Million USD | -20.75% |
| 2019 FY | - USD | 37.14% |
| 2019 Q4 | 1.23 Million USD | 11.68% |
| 2019 Q1 | 1.88 Million USD | 35.18% |
| 2019 Q2 | 1.39 Million USD | -26.02% |
| 2018 Q2 | 808 Thousand USD | -22.68% |
| 2018 Q4 | 1.39 Million USD | 60.67% |
| 2018 Q3 | 867 Thousand USD | 7.3% |
| 2018 FY | - USD | 22.11% |
| 2018 Q1 | 1.04 Million USD | 25.6% |
| 2017 Q3 | 1.49 Million USD | 260.34% |
| 2017 Q4 | 832 Thousand USD | -44.5% |
| 2017 FY | - USD | 147.58% |
| 2017 Q1 | 548 Thousand USD | 176.77% |
| 2017 Q2 | 416 Thousand USD | -24.09% |
| 2016 FY | - USD | 535.53% |
| 2016 Q4 | 198 Thousand USD | -55.2% |
| 2016 Q2 | 562 Thousand USD | 1024.0% |
| 2016 Q3 | 442 Thousand USD | -21.35% |
| 2016 Q1 | 50 Thousand USD | -28.57% |
| 2015 FY | - USD | -15.64% |
| 2015 Q1 | -61 Thousand USD | -153.51% |
| 2015 Q2 | -257 Thousand USD | -321.31% |
| 2015 Q4 | 70 Thousand USD | 128.0% |
| 2015 Q3 | -250 Thousand USD | 2.72% |
| 2014 FY | - USD | 79.01% |
| 2014 Q4 | 114 Thousand USD | 135.4% |
| 2014 Q3 | -322 Thousand USD | -49.77% |
| 2014 Q2 | -215 Thousand USD | -240.52% |
| 2014 Q1 | 153 Thousand USD | 127.82% |
| 2013 FY | - USD | -82.45% |
| 2013 Q3 | -626 Thousand USD | -168.67% |
| 2013 Q2 | -233 Thousand USD | -335.35% |
| 2013 Q1 | 99 Thousand USD | 115.3% |
| 2013 Q4 | -550 Thousand USD | 12.14% |
| 2012 Q3 | -518 Thousand USD | -362.5% |
| 2012 FY | - USD | -118.22% |
| 2012 Q4 | -647 Thousand USD | -24.9% |
| 2012 Q2 | -112 Thousand USD | -117.89% |
| 2012 Q1 | 626 Thousand USD | -52.72% |
| 2011 FY | - USD | 102.94% |
| 2011 Q1 | 577 Thousand USD | 20.71% |
| 2011 Q2 | 741 Thousand USD | 28.42% |
| 2011 Q3 | 1.29 Million USD | 75.17% |
| 2011 Q4 | 1.32 Million USD | 2.0% |
| 2010 Q3 | 584 Thousand USD | 27.51% |
| 2010 Q4 | 478 Thousand USD | -18.15% |
| 2010 Q2 | 458 Thousand USD | 8.53% |
| 2010 FY | - USD | 512.62% |
| 2010 Q1 | 422 Thousand USD | -4.09% |
| 2009 Q1 | 64 Thousand USD | 110.72% |
| 2009 Q2 | 280 Thousand USD | 337.5% |
| 2009 FY | - USD | -67.25% |
| 2009 Q3 | -477 Thousand USD | -270.36% |
| 2009 Q4 | 440 Thousand USD | 192.24% |
| 2008 FY | - USD | -25.25% |
| 2008 Q2 | 562 Thousand USD | -11.36% |
| 2008 Q3 | 369 Thousand USD | -34.34% |
| 2008 Q4 | -597 Thousand USD | -261.79% |
| 2008 Q1 | 634 Thousand USD | 25.3% |
| 2007 Q4 | 506 Thousand USD | 6.98% |
| 2007 Q1 | 534 Thousand USD | 83.51% |
| 2007 FY | - USD | -11.9% |
| 2007 Q2 | -196 Thousand USD | -136.7% |
| 2007 Q3 | 473 Thousand USD | 341.33% |
| 2006 Q4 | 291 Thousand USD | 150.86% |
| 2006 Q3 | 116 Thousand USD | -79.06% |
| 2006 Q2 | 554 Thousand USD | 9.06% |
| 2006 Q1 | 508 Thousand USD | -54.15% |
| 2006 FY | - USD | -41.74% |
| 2005 FY | - USD | 21.59% |
| 2005 Q1 | 703 Thousand USD | -3.83% |
| 2005 Q2 | 385 Thousand USD | -45.23% |
| 2005 Q3 | 328 Thousand USD | -14.81% |
| 2005 Q4 | 1.1 Million USD | 237.8% |
| 2004 Q3 | 436 Thousand USD | -11.02% |
| 2004 Q2 | 490 Thousand USD | 16.95% |
| 2004 Q4 | 731 Thousand USD | 67.66% |
| 2004 FY | - USD | 221.71% |
| 2004 Q1 | 419 Thousand USD | 56.34% |
| 2003 Q1 | 111 Thousand USD | 109.67% |
| 2003 FY | - USD | 156.23% |
| 2003 Q4 | 300 Thousand USD | 48.07% |
| 2003 Q3 | 189 Thousand USD | 98.9% |
| 2003 Q2 | 81 Thousand USD | -13.33% |
| 2002 Q3 | 69 Thousand USD | 116.2% |
| 2002 Q4 | -1.28 Million USD | -2460.87% |
| 2002 FY | - USD | -224.4% |
| 2002 Q1 | 199 Thousand USD | 112.24% |
| 2002 Q2 | -253 Thousand USD | -261.36% |
| 2001 Q2 | 484 Thousand USD | -19.4% |
| 2001 Q3 | -155 Thousand USD | -96.67% |
| 2001 FY | - USD | -81.26% |
| 2001 Q4 | -1.93 Million USD | -4400.11% |
| 2001 Q1 | 1.08 Million USD | -11.15% |
| 2000 Q3 | 1.08 Million USD | -41.39% |
| 2000 FY | - USD | 442.93% |
| 2000 Q4 | 1.39 Million USD | 32.89% |
| 2000 Q2 | 1.8 Million USD | 157.14% |
| 2000 Q1 | 700 Thousand USD | 397.87% |
| 1999 Q2 | -700 Thousand USD | -450.0% |
| 1999 Q4 | -6.82 Million USD | 60.83% |
| 1999 Q3 | -600 Thousand USD | 14.29% |
| 1999 Q1 | -600 Thousand USD | -1.38% |
| 1999 FY | - USD | -149.44% |
| 1998 FY | - USD | 38.23% |
| 1998 Q1 | 1.1 Million USD | 83.33% |
| 1998 Q2 | 1.1 Million USD | 0.0% |
| 1998 Q3 | 400 Thousand USD | -63.64% |
| 1998 Q4 | 202.79 Thousand USD | -49.3% |
| 1997 Q4 | 600 Thousand USD | 700.0% |
| 1997 Q2 | 700 Thousand USD | 250.0% |
| 1997 Q1 | 200 Thousand USD | -77.78% |
| 1997 Q3 | -100 Thousand USD | -114.29% |
| 1997 FY | - USD | -44.74% |
| 1996 Q1 | 900 Thousand USD | 100.0% |
| 1996 Q3 | 1 Million USD | 75.0% |
| 1996 FY | - USD | 171.43% |
| 1996 Q4 | 900 Thousand USD | -35.71% |
| 1996 Q2 | 800 Thousand USD | -20.0% |
| 1995 Q3 | 100 Thousand USD | -50.0% |
| 1995 Q4 | 500 Thousand USD | 400.0% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | -66.67% |
| 1995 FY | - USD | 27.27% |
| 1994 Q2 | 300 Thousand USD | 50.0% |
| 1994 Q3 | 200 Thousand USD | -33.33% |
| 1994 Q4 | 300 Thousand USD | 50.0% |
| 1994 FY | - USD | 266.67% |
| 1994 Q1 | 200 Thousand USD | 150.0% |
| 1993 Q3 | 200 Thousand USD | 0.0% |
| 1993 FY | - USD | -57.14% |
| 1993 Q4 | -400 Thousand USD | -300.0% |
| 1993 Q1 | 100 Thousand USD | -87.5% |
| 1993 Q2 | 200 Thousand USD | 100.0% |
| 1992 Q3 | 200 Thousand USD | -83.33% |
| 1992 FY | - USD | 600.0% |
| 1992 Q4 | 600 Thousand USD | 300.0% |
| 1992 Q1 | 1.1 Million USD | 168.75% |
| 1992 Q2 | 1.2 Million USD | 9.09% |
| 1991 Q1 | 500 Thousand USD | 135.71% |
| 1991 Q2 | 500 Thousand USD | 0.0% |
| 1991 FY | - USD | -80.0% |
| 1991 Q3 | 600 Thousand USD | 20.0% |
| 1991 Q4 | -1.6 Million USD | -366.67% |
| 1990 Q4 | -1.4 Million USD | -333.33% |
| 1990 FY | - USD | 25.0% |
| 1990 Q2 | 500 Thousand USD | -16.67% |
| 1990 Q1 | 600 Thousand USD | 137.5% |
| 1990 Q3 | 600 Thousand USD | 20.0% |
| 1989 Q4 | -1.6 Million USD | -500.0% |
| 1989 Q1 | 600 Thousand USD | 117.65% |
| 1989 Q2 | 500 Thousand USD | -16.67% |
| 1989 FY | - USD | 133.33% |
| 1989 Q3 | 400 Thousand USD | -20.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 118.261% |
| AngioDynamics, Inc. | -14.29 Million USD | 158.305% |
| AtriCure, Inc. | -8.1 Million USD | 202.762% |
| Avinger, Inc. | -16.34 Million USD | 150.979% |
| Azenta, Inc. | 55.15 Million USD | 84.891% |
| BioLife Solutions, Inc. | -45.23 Million USD | 118.42% |
| The Cooper Companies, Inc. | 882.8 Million USD | 99.056% |
| Daxor Corporation | 329.74 Thousand USD | -2427.143% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 163.138% |
| Femasys Inc. | -13.16 Million USD | 163.275% |
| GlucoTrack, Inc. | -7.09 Million USD | 217.515% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 12.22% |
| Hologic, Inc. | 1.29 Billion USD | 99.357% |
| ICU Medical, Inc. | 307.69 Million USD | 97.292% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 99.652% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 188.653% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 82.99% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 226.735% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 226.735% |
| Masimo Corporation | 236.7 Million USD | 96.48% |
| Microbot Medical Inc. | -10.63 Million USD | 178.362% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 47.161% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 96.4% |
| Nephros, Inc. | -1.37 Million USD | 704.278% |
| NovoCure Limited | -175.86 Million USD | 104.738% |
| NEXGEL, Inc. | -2.73 Million USD | 405.238% |
| NEXGEL, Inc. | -2.73 Million USD | 405.238% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 109.634% |
| OraSure Technologies, Inc. | 76.15 Million USD | 89.058% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 119.669% |
| Predictive Oncology Inc. | -13.18 Million USD | 163.215% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 431.734% |
| QuidelOrtho Corporation | 545.6 Million USD | 98.473% |
| Repligen Corporation | 124.29 Million USD | 93.296% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 2982.424% |
| STAAR Surgical Company | 33.22 Million USD | 74.916% |
| Sharps Technology, Inc. | -8.98 Million USD | 192.791% |
| Utah Medical Products, Inc. | 24.8 Million USD | 66.406% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 96.408% |
| Jin Medical International Ltd. | 3.44 Million USD | -142.035% |